FDA clears Medtronic Hugo for general surgery procedures
Image: Medtronic / PR Newswire · press-kit
On 17 November 2026 Medtronic announced FDA clearance of the Hugo robotic system for upper and lower abdominal general surgery.
Medtronic announced on 17 November 2026 that the US Food and Drug Administration cleared the Hugo robotic-assisted surgery system for general surgery procedures. The clearance covers upper abdominal procedures, including cholecystectomy, Roux-en-Y gastric bypass, ventral hernia repair and small bowel resection, and lower abdominal procedures such as inguinal hernia repair and appendectomy.
Medtronic says these procedures represent about 3.5 million US surgeries a year, more than half of US soft-tissue procedures. The company expects Hugo to pass 50,000 procedures by the end of its fiscal year, and says the LigaSure RAS Maryland vessel-sealing instrument is now available for use with the system.
The clearance is an expanded 510(k) and the release does not give a US launch schedule or pricing. The procedure volumes and the 50,000 projection are Medtronic figures.
Sources
- Medtronic (PR Newswire, via Yahoo Finance) Primary source
